Nicotinamide Mononucleotide NMN Market Report 2025 (Global Edition)

Global Nicotinamide Mononucleotide NMN Market Report 2025 Market Size Split by Product Form (Capsules/Pills, Powder, Liquid), by Application (Anti-Aging, Metabolic Health, Athletic Performance, Others...

Nicotinamide Mononucleotide NMN Market Report Description

We have various report editions of Nicotinamide Mononucleotide NMN Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Nicotinamide Mononucleotide NMN Market Insights Video

Competitive Landscape of the Nicotinamide Mononucleotide NMN Market

The NMN market features a competitive landscape characterized by a mix of established players and emerging entrants focusing on product innovation and market expansion. Key players such as ChromaDex Corporation, Elysium Health, and ProHealth Longevity are prominent in the market, leveraging their research capabilities and brand recognition to maintain market dominance.

December 2021: Novo Nordisk acquired Dicerna Pharmaceuticals. With the completion of the merger, Dicerna became a wholly-owned subsidiary of Novo Nordisk. The common stock of Dicerna will not be disclosed on listed or traded on the Nasdaq Global Select Market.

(Source: https://www.novonordisk.com/content/nncorp/global/en/news-and-media/news-and-ir-materials/news-details.html?id=93736)

October 2022: the dietary supplement expert ChromaDex (NR). The results showed that NR could increase NAD+ levels, making it an innovative treatment for heart failure with a lower ejection fraction.

(Source: https://www.ahajournals.org/doi/10.1161/circulationaha.116.026099)

Top Companies Market Share in Nicotinamide Mononucleotide NMN Industry: (In no particular order of Rank)

• Herbalmax
• Genex Formulas
• Kindomway
• CELFULL
• GeneHarbor
• Maac10 Formulas
• Bontac
• MIRAILAB BIOSCIENCE Inc.
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Nicotinamide Mononucleotide NMN Market

Which Region Dominates the Nicotinamide Mononucleotide NMN Market in 2024?

According to Cognitive Market Research, North America leads in the Nicotinamide Mononucleotide (NMN) market due to several key factors. The region's advanced healthcare infrastructure supports extensive research and development activities, fostering innovation in NMN-based products. Additionally, a robust regulatory framework ensures stringent quality standards, enhancing consumer trust and market growth. North America's proactive approach to wellness trends and aging populations drives demand for NMN, known for its potential anti-aging properties and health benefits.

Which Region is Expanding at the Fastest CAGR?

Asia Pacific is the fastest-growing region in the Nicotinamide Mononucleotide (NMN) market primarily due to rising health consciousness and aging demographics. Countries like Japan and China are at the forefront, with increasing disposable incomes and a strong focus on preventive healthcare. The region benefits from a burgeoning pharmaceutical and nutraceutical industry, driving research and product development in NMN. Moreover, favorable government initiatives and regulatory support for dietary supplements contribute to market expansion.

 

The current report Scope analyzes Nicotinamide Mononucleotide NMN Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America Nicotinamide Mononucleotide NMN Market

As per the current market study, out of 278.4 Million USD global market revenue 2025, North America market holds 28.99% of the market share. The North America Nicotinamide Mononucleotide NMN industry grew from 60.3 Million USD in 2021 to 80.7 Million USD in 2025 and will record 74.72% growth. In coming future this industry will reach 145.6 Million by 2033 with a 7.7% CAGR. If we look at the percentage market shares of top North America countries for 2025,Canada (12.52%), United States (78.93%), Mexico (8.55%)

According to Cognitive Market Research, the global Nicotinamide Mononucleotide NMN market size was estimated at USD 115.9 Million, out of which North America held the major market of more than 40% of the global revenue with a market size of USD 46.36million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.2%from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the Nicotinamide Mononucleotide NMN market with a market size of USD 36.58million in 2024 and is projected to grow at a CAGR of 4.0% during the forecast period. The demand is amplified by the nation's increasing awareness and adoption of anti-aging solutions among the aging population.
• The Canada Nicotinamide Mononucleotide NMN market had a market share of USD 5.56million in 2024 and is projected to grow at a CAGR of 5.0% during the forecast period. Canada's increasing awareness and adoption of anti-aging solutions among the aging population to increased usage of Nicotinamide Mononucleotide NMN.
• The Mexico Nicotinamide Mononucleotide NMN market is projected to witness growth at a CAGR of 4.7%during the forecast period,with a market size of USD 4.22million in 2024.

Europe Nicotinamide Mononucleotide NMN Market

As per the current market study, out of 278.4 Million USD global market revenue 2025, Europe market holds 27.01% of the market share. The Europe Nicotinamide Mononucleotide NMN industry grew from 55.7 Million USD in 2021 to 75.2 Million USD in 2025 and will record 74.07% growth. In coming future this industry will reach 136.3 Million by 2033 with a 7.7% CAGR. If we look at the percentage market shares of top Europe countries for 2025,Spain (7.45%), United Kingdom (18.75%), Russia (8.64%), Italy (12.77%), Germany (24.34%), France (15.56%), Luxembourg (2.66%), Rest of Europe (1.33%)

According to Cognitive Market Research, the global Nicotinamide Mononucleotide NMN market size was estimated at USD 115.9 Million out of which Europe held the market of more than 30% of the global revenue with a market size of USD 34.77million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.5%from 2024 to 2031.

• The United Kingdom Nicotinamide Mononucleotide NMN market had a market share of USD 5.84million in 2024 and is projected to grow at a CAGR of 5.3% during the forecast period. In the UK, Nicotinamide Mononucleotide NMN sales witness an upswing due to the nation's increasing health consciousness and aging demographics.
• The France Nicotinamide Mononucleotide NMN market is projected to witness growth at a CAGR of 3.7%during the forecast period,with a market size of USD 3.20 million in 2024.
• According to Cognitive Market Research, the Germany Nicotinamide Mononucleotide NMN market size was valued at USD 6.88million in 2024 and is projected to grow at a CAGR of 4.7% during the forecast period. In Germany, Nicotinamide Mononucleotide NMN sales surged due to the increasing health consciousness and aging demographics.
• The Italy Nicotinamide Mononucleotide NMN market is projected to witness growth at a CAGR of 3.9% during the forecast period, with a market size of USD 2.99million in 2024.
• The Russia Nicotinamide Mononucleotide NMN market is projected to witness growth at a CAGR of 3.5% during the forecast period,with a market size of USD 5.39 million in 2024.
• The Spain Nicotinamide Mononucleotide NMN market is projected to witness growth at a CAGR of 3.6% during the forecast period with a market size of USD 2.85 million in 2024
• The LuxembourgNicotinamide Mononucleotide NMN market is projected to witness growth at a CAGR of 4.6%during the forecast period, with a market size of USD 1.08million in 2024.
• The PortugalNicotinamide Mononucleotide NMN market is projected to witness growth at a CAGR of 4.3%during the forecast period, with a market size of USD 0.73million in 2024.
• The GreeceNicotinamide Mononucleotide NMN market is projected to witness growth at a CAGR of 4.8%during the forecast period, with a market size of USD 0.42million in 2024.
• Rest of Europe'sNicotinamide Mononucleotide NMN market is projected to witness growth at a CAGR of 3.2%during the forecast period, with a market size of USD 5.39million in 2024.

Asia Pacific Nicotinamide Mononucleotide NMN Market

As per the current market study, out of 278.4 Million USD global market revenue 2025, Asia Pacific market holds 28.41% of the market share. The Asia Pacific Nicotinamide Mononucleotide NMN industry grew from 56.7 Million USD in 2021 to 79.1 Million USD in 2025 and will record 71.68% growth. In coming future this industry will reach 152.9 Million by 2033 with a 8.6% CAGR. If we look at the percentage market shares of top Asia Pacific countries for 2025,South East Asia (11.25%), Korea (15.55%), Japan (20.86%), China (30.59%), Australia (5.31%), India (12.64%), Rest of APAC (3.54%)

According to Cognitive Market Research, the global Nicotinamide Mononucleotide NMN market size was estimated at USD 115.9Million, out of which Asia Pacific held the market ofaround23% of the global revenue with a market size of USD 26.66million in 2024 and will grow at a compound annual growth rate (CAGR) of 8.0%from 2024 to 2031.

• According to Cognitive Market Research, the China Nicotinamide Mononucleotide NMN market size was valued at USD 12.00 million in 2024 and is projected to grow at a CAGR of 7.5% during the forecast period. Nicotinamide Mononucleotide NMN sales surge in China due to the increasing consumer awareness and rising disposable incomes.
• The Japan Nicotinamide Mononucleotide NMN market is projected to witness growth at a CAGR of 6.5% during the forecast period, with a market size of USD 3.68million in 2024.
• The India Nicotinamide Mononucleotide NMN market had a market share of USD 3.20 million in 2024 and is projected to grow at a CAGR of 9.8% during the forecast period. India's increasing consumer awareness and rising disposable incomes.
• The South Korea Nicotinamide Mononucleotide NMN market is projected to witness growth at a CAGR of 7.1%during the forecast period,with a market size of USD 2.67 million in 2024.
• The Australia Nicotinamide Mononucleotide NMN market is projected to witness growth at a CAGR of 5.7% during the forecast period, with a market size of USD 1.39million in 2024.
• The South East Asia Nicotinamide Mononucleotide NMN market is projected to witness growth at a CAGR of 9.0%during the forecast period, with a market size of USD 1.84million in 2024.
• The Rest of Asia Pacific Nicotinamide Mononucleotide NMN market is projected to witness growth at a CAGR of 7.8%during the forecast period, with a market size of USD 1.89million in 2024.

South America Nicotinamide Mononucleotide NMN Market

As per the current market study, out of 278.4 Million USD global market revenue 2025, South America market holds 7.51% of the market share. The South America Nicotinamide Mononucleotide NMN industry grew from 15.1 Million USD in 2021 to 20.9 Million USD in 2025 and will record 72.25% growth. In coming future this industry will reach 40 Million by 2033 with a 8.5% CAGR. If we look at the percentage market shares of top South America countries for 2025,Argentina (19.14%), Brazil (39.23%), Chile (7.66%), Peru (6.22%), Colombia (15.79%), Rest of South America (11.96%)

According to Cognitive Market Research, the global Nicotinamide Mononucleotide NMN market size was estimated at USD 115.9 Million out of which Latin America market of more than 5% of the global revenue with a market size of USD 5.80 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.4%from 2024 to 2031.

• According to Cognitive Market Research, the Brazil Nicotinamide Mononucleotide NMN market size was valued at USD 2.48 million in 2024 and is projected to grow at a CAGR of 6.0% during the forecast period. Nicotinamide Mononucleotide NMN sales flourish in Brazil due to the increasing health consciousness and a growing aging population.
• Argentina Nicotinamide Mononucleotide NMN market had a market share of USD 0.97million in 2024 and is projected to grow at a CAGR of 6.3% during the forecast period. Argentina's increasing health consciousness and a growing aging population.
• Colombia Nicotinamide Mononucleotide NMN market is projected to witness growth at a CAGR of 5.2% during the forecast period with a market size of USD 0.52 million in 2024.
• Peru Nicotinamide Mononucleotide NMN market is projected to witness growth at a CAGR of 5.6% during the forecast period with a market size of USD 0.48million in 2024.
• Chile Nicotinamide Mononucleotide NMN market is projected to witness growth at a CAGR of 5.7% during the forecast period with a market size of USD 0.42 million in 2024.
• The Rest of Latin America Nicotinamide Mononucleotide NMN market is projected to witness growth at a CAGR of 4.5% during the forecast period, with a market size of USD 0.93 million in 2024.

Middle East and Africa Nicotinamide Mononucleotide NMN Market

As per the current market study, out of 278.4 Million USD global market revenue 2025, Middle East and Africa market holds 8.12% of the market share. The Middle East and Africa Nicotinamide Mononucleotide NMN industry grew from 16.1 Million USD in 2021 to 22.6 Million USD in 2025 and will record 71.24% growth. In coming future this industry will reach 44.4 Million by 2033 with a 8.8% CAGR. If we look at the percentage market shares of top Middle East and Africa countries for 2025,Egypt (15.93%), Turkey (14.60%), Rest of MEA (11.95%)

According to Cognitive Market Research, the global Nicotinamide Mononucleotide NMN market size was estimated at USD 115.9 Million, out of which the Middle East and Africa held the major market ofaround 2% of the global revenue with a market size of USD 2.32million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.7%from 2024 to 2031

• The GCC Countries Nicotinamide Mononucleotide NMN market is projected to witness growth at a CAGR of 6.5% during the forecast period with a market size of USD 0.99 million in 2024. Nicotinamide Mononucleotide NMN sales flourish due to the increasing awareness of health and wellness trends.
• The Egypt Nicotinamide Mononucleotide NMN market is projected to witness growth at a CAGR of 6.0%during the forecast period,with a market size of USD 0.24million in 2024.
• The South Africa Nicotinamide Mononucleotide NMN market is projected to witness growth at a CAGR of 6.7% during the forecast period,with a market size of USD 0.37million in 2024. Nicotinamide Mononucleotide NMN sales flourish in South Africa due to the increasing awareness of health and wellness trends.
• The Turkey Nicotinamide Mononucleotide NMN market is projected to witness growth at a CAGR of 5.2% during the forecast period, with a market size of USD 0.20 million in 2024.
• The Nigeria Nicotinamide Mononucleotide NMN market is projected to witness growth at a CAGR of 4.8%during the forecast period, with a market size of USD 0.24 million in 2024.
• The Rest of MEA Nicotinamide Mononucleotide NMN market is projected to witness growth at a CAGR of 4.7% during the forecast period, with a market size of USD 0.27 million in 2024.

Nicotinamide Mononucleotide NMN Market Analysis

Nicotinamide Mononucleotide NMN MarketProduct FormSegment Analysis

According to Cognitive Market Research, Capsules and pills are currently the dominant category in the Nicotinamide Mononucleotide (NMN) market. This form is preferred by consumers due to its convenience and ease of use. Capsules and pills offer precise dosing, making it simpler for users to regulate their intake of NMN supplements daily. Moreover, this form provides a longer shelf life compared to liquid formulations, appealing to both consumers and retailers alike. The encapsulation or pill format also ensures stability and protects NMN from degradation, preserving its potency over time.

Powdered NMN supplements are witnessing the fastest growth in the market. This trend is driven by the versatility and flexibility that powdered form offers to consumers. Powdered NMN can be easily mixed into beverages or added to food, providing a convenient way for users to incorporate NMN into their daily routines. Additionally, powdered supplements often boast higher bioavailability compared to capsules or pills, appealing to health-conscious consumers seeking maximum efficacy from their supplements. The ability to customize dosage by easily measuring out powder also adds to its popularity among users looking for personalized health solutions.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Nicotinamide Mononucleotide NMN Industry. Request a Free Sample PDF!

Nicotinamide Mononucleotide NMN Market Application Segment Analysis

According to Cognitive Market Research, The dominant category in the Nicotinamide Mononucleotide (NMN) market is Anti-Aging applications. NMN has gained significant popularity among consumers interested in anti-aging solutions due to its role in cellular health and longevity. As individuals seek ways to maintain youthful vigor and combat the effects of aging, NMN supplements have emerged as a promising option. Research suggesting NMN's ability to enhance cellular metabolism and mitochondrial function aligns perfectly with anti-aging goals, making it a preferred choice among health-conscious consumers.

The Metabolic health is emerging as the fastest-growing category in the NMN market. NMN's ability to support metabolic functions, such as glucose metabolism and energy production, is driving its popularity in this segment. Consumers are increasingly turning to NMN supplements to manage metabolic disorders, improve insulin sensitivity, and enhance overall metabolic efficiency. The scientific evidence supporting NMN's role in metabolic health, including its potential benefits for weight management and cardiovascular health, is fueling the rapid growth of this category.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Nicotinamide Mononucleotide NMN Distribution Channel Segment Analysis

Distribution Channel Segment Analysis

According to Cognitive Market Research, Online retail is currently the dominant distribution channel in the Nicotinamide Mononucleotide (NMN) market. The convenience and widespread availability of NMN supplements through e-commerce platforms have significantly contributed to the dominance of online retail. Consumers appreciate the ease of browsing and purchasing NMN products from the comfort of their homes, with access to a wide range of brands and formulations at competitive prices. Online retailers also provide detailed product information, customer reviews, and convenient delivery options, enhancing the overall shopping experience.

Offline retail is experiencing rapid growth in the NMN market, particularly through health food stores, pharmacies, and specialty supplement stores. The tactile experience of physically examining products and interacting with knowledgeable staff appeals to consumers seeking personalized guidance on NMN supplements. Offline retailers often provide a trusted environment where consumers can ask questions, receive recommendations, and make informed decisions about their health and wellness goals.

• Online Retail
• Offline Retail

Author's Detail

Manoj Phagare

Senior Research Analyst at Cognitive Market Research

LinkedIn

Profile

• Worked on several market, industry & business research projects, on various models such as Syndicated, Custom, Subscriptions and Consults
• Proficient in secondary research and familiar with all paid research databases
• Proficient in primary research and handling client queries through mails and calls
• Expertise in statistical techniques used in data forecasting, possess strong grip on all aspects of market engineering & data analysis
• Expertise in checking feasibility of projects based on Request for Proposal (RFPs) of clients
• Acquainted with entire process of report writing- Title Analysis, TOC Building, Search Engine Optimization, TOC Freezing, Writing Reports, Market Engineering, Scheduling Primaries, Directory of Key Industry Participants (DKIP), Drafting “Press Articles/Summary/Report Description/Analyst Briefing” used for making marketing collaterals 
• Gained team-work skills in coordinating with the sales teams for business development and meeting needs of a variety of clients hand-in-hand with promoting sales.

Author's Conclusion